Researchers who set out to compare the ability of SNP and comparative genomic hybridization microarray platforms to detect copy number variation in autusm spectrum disorder managed to identify 16 genes that hadn't been associated with ASD before.
NEW YORK (GenomeWeb News) – SynapDx today announced the completion of a Series A1 financing round that brought in $6 million to support a clinical study in support of the company's test for autism spectrum disorders.
NEW YORK (GenomeWeb News) – Roche today announced that it has teamed with the Innovative Medicines Initiative to lead a consortium of industry and academic partners that will use stem cells for drug discovery research.
The Center for Autism and Related Disorders, a provider of early intensive behavioral intervention for individuals with autism spectrum disorder, will now offer Lineagen's FirstStepDx test as a service to CARD patients and their families.
NEW YORK (GenomeWeb News) – Autism Speaks said today that its nonprofit affiliate Delivering Scientific Innovation for Autism (DELSIA) will provide $2 million for a biomarker discovery project with Seaside Therapeutics, a drug developer that plans to market a new personalized treatment.
As new studies continue to elucidate the link between structural variants and disease, these variants are increasingly associated with multiple distinct diseases, complicating their diagnostic utility.
NEW YORK (GenomeWeb News) – A new study in the New England Journal of Medicine is underscoring the importance of de novo mutations in non-syndromic intellectual disability, while highlighting the potential of using exome sequencing to diagnose severe intellectual disability case
NEW YORK (GenomeWeb News) – Bioinformatics firm BioDiscovery and the Autism Genetic Resource Exchange today announced a co-marketing agreement that allows AGRE to provide copy number and allelic event data to its researchers through BioDiscovery's Nexus DB platform.